Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. ARDT
ARDT logo

ARDT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
9.025
Open
8.950
VWAP
8.92
Vol
107.19K
Mkt Cap
1.29B
Low
8.830
Amount
956.33K
EV/EBITDA(TTM)
3.91
Total Shares
142.86M
EV
2.08B
EV/OCF(TTM)
4.42
P/S(TTM)
0.20
Ardent Health, Inc., formerly Ardent Health Partners, Inc., is a provider of healthcare in mid-sized urban communities across the United States. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings.
Show More

Events Timeline

(ET)
2026-03-04
16:30:00
Sees FY26 Revenue at $6.4B-$6.7B, Consensus $6.64B
select
2026-03-04
16:30:00
Ardent Health Q4 Revenue at $1.605B, Below Consensus
select
2025-11-18 (ET)
2025-11-18
09:30:38
Ardent Health unveils $50 million stock buyback initiative
select

News

Globenewswire
7.0
03-09Globenewswire
Class Action Lawsuits Filed Against Varonis and Ardent Health
  • Varonis Lawsuit Overview: Shareholders of Varonis Systems, Inc. are facing losses from February 4 to October 28, 2025, due to the company's failure to disclose its ability to sustain growth, leading to a misunderstanding of its prospects, with a class action deadline of March 9, 2026.
  • Ardent Lawsuit Details: Similarly, shareholders of Ardent Health, Inc. from July 18, 2024, to November 12, 2025, encountered issues as the company misrepresented the collectability of accounts receivable, resulting in a misjudgment of its financial health, with the same class action deadline of March 9, 2026.
  • Legal Consultation Advice: The Law Offices of Frank R. Cruz remind investors who suffered losses during the specified periods to contact the firm to understand their legal rights, providing contact details including phone and email.
  • Class Action Participation Note: Investors need not take immediate action to be part of the class action, and the law firm offers various contact methods for shareholders to obtain more information and consultation.
Globenewswire
7.0
03-09Globenewswire
Class Action Lawsuit Reminder Against Ardent Health, Inc.
  • Class Action Notification: The Schall Law Firm reminds investors of a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) for securities purchased between July 18, 2024, and November 12, 2025, urging affected investors to contact the firm by March 9, 2026, to participate.
  • False Statement Allegations: The complaint alleges that Ardent made false and misleading statements, claiming reliance on 'detailed reviews of historical collections' to assess collectible accounts receivable, which was not the case, leading to investor losses.
  • Loss Recognition Delay: The company utilized a 180-day cliff policy to delay recognizing losses on uncollectable accounts, which resulted in a failure to accurately reflect its financial condition in reports, exacerbating investor losses.
  • Insufficient Liability Insurance: Ardent Health failed to maintain adequate levels of professional malpractice liability insurance, which could expose the company to greater financial risks in the event of legal actions, potentially impacting its operational stability going forward.
Globenewswire
7.0
03-08Globenewswire
Ardent Health Faces Class Action Lawsuit
  • Lawsuit Background: Bragar Eagel & Squire has filed a class action lawsuit against Ardent Health (ARDT) on behalf of investors who purchased securities between July 18, 2024, and November 12, 2025, alleging failure to timely recognize uncollectible accounts, resulting in investor losses.
  • Financial Missteps: Ardent Health reported a $43 million revenue decrease in Q3 2025, primarily due to a transition to a new revenue accounting system and revised assessments of historical collection trends, leading to a 34% drop in stock price in one day.
  • Insurance Gaps: The complaint highlights that Ardent Health did not maintain sufficient professional malpractice liability insurance, raising concerns about its ability to cover claims arising from its operations, which further exacerbates investor anxiety.
  • Investor Action: Investors must apply by March 9, 2026, to be appointed as lead plaintiffs in the lawsuit, with Bragar Eagel & Squire offering free consultations and encouraging affected investors to reach out to understand their legal rights.
Globenewswire
7.0
03-08Globenewswire
Ardent Health Faces Class Action Lawsuit
  • Lawsuit Background: Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Ardent Health and certain officers, alleging violations of federal securities laws from July 18, 2024, to November 12, 2025, seeking damages for affected investors.
  • Financial Misstatements: The complaint alleges that Ardent Health overstated its Q3 2025 revenue due to inadequate assessments of accounts receivable collectability following a transition to a new revenue accounting system, misleading investors about the company's financial health.
  • EBITDA Guidance Reduction: The company anticipates a $57.5 million reduction in its 2025 EBITDA guidance, approximately 9.6%, primarily due to persistent industry-wide cost pressures and payer denials, which further undermines investor confidence.
  • Investor Action Recommendations: Affected investors have until March 9, 2026, to request lead plaintiff status, with the law firm operating on a contingency fee basis, thereby minimizing legal risks for investors seeking recovery.
Globenewswire
7.0
03-08Globenewswire
Ardent Health Securities Class Action Notice
  • Class Action Initiation: Rosen Law Firm reminds investors who purchased Ardent Health securities between July 18, 2024, and November 12, 2025, to apply as lead plaintiffs by March 9, 2026, or risk not being represented in the lawsuit.
  • Compensation Mechanism: Participants can receive compensation through a contingency fee arrangement without upfront costs, indicating a low-risk legal avenue for affected investors, which may encourage more to join the action.
  • False Statements Exposed: The lawsuit alleges that Ardent Health made false representations regarding its accounts receivable, failing to accurately reflect their collectability, leading to investor losses when the truth was revealed, thereby impacting the company's reputation and future financing capabilities.
  • Law Firm's Credentials: Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, demonstrating its expertise and effectiveness in handling such cases.
Globenewswire
7.0
03-07Globenewswire
Ardent Health Faces Class Action for Securities Fraud
  • Lawsuit Background: Bleichmar Fonti & Auld LLP has filed a class action against Ardent Health and its executives, alleging securities fraud after a 33% stock drop on November 12, 2025, due to unrecognized uncollectible receivables.
  • Financial Misrepresentation: The lawsuit claims Ardent Health falsely stated it relied on 'detailed reviews of historical collections' for receivables, while actually using a 180-day cliff to delay loss recognition, undermining investor confidence.
  • Stock Price Impact: Following the announcement of a $43 million revenue decrease and a $54 million increase in professional liability reserves on November 12, 2025, Ardent Health's stock plummeted from $14.05 to $9.30, reflecting a drop of over 33%.
  • Legal Consequences: Investors have until March 9, 2026, to apply to lead the case, which could impose legal liabilities on Ardent Health's executives and affect the company's future operations and financial health.
Wall Street analysts forecast ARDT stock price to rise
13 Analyst Rating
Wall Street analysts forecast ARDT stock price to rise
8 Buy
4 Hold
1 Sell
Moderate Buy
Current: 0.000
sliders
Low
10.00
Averages
13.73
High
17.00
Current: 0.000
sliders
Low
10.00
Averages
13.73
High
17.00
UBS
AJ Rice
Buy
downgrade
$14 -> $13
AI Analysis
2026-03-06
New
Reason
UBS
AJ Rice
Price Target
$14 -> $13
AI Analysis
2026-03-06
New
downgrade
Buy
Reason
UBS analyst AJ Rice lowered the firm's price target on Ardent Health to $13 from $14 and keeps a Buy rating on the shares.
Leerink
Outperform
downgrade
$16 -> $15
2026-03-06
New
Reason
Leerink
Price Target
$16 -> $15
2026-03-06
New
downgrade
Outperform
Reason
Leerink lowered the firm's price target on Ardent Health to $15 from $16 and keeps an Outperform rating on the shares. The firm says the company's Q4 results were better than last quarter with stabilization in payer denials and professional fees, solid volumes, and good expense management. Leerink believes the shares are trading at an "overly harsh" valuation given Ardent's growth prospects.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ARDT
Unlock Now

Valuation Metrics

The current forward P/E ratio for Ardent Health Inc (ARDT.N) is 6.68, compared to its 5-year average forward P/E of 8.38. For a more detailed relative valuation and DCF analysis to assess Ardent Health Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
8.38
Current PE
6.68
Overvalued PE
10.23
Undervalued PE
6.53

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
7.57
Current EV/EBITDA
6.56
Overvalued EV/EBITDA
8.79
Undervalued EV/EBITDA
6.34

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.33
Current PS
0.19
Overvalued PS
0.40
Undervalued PS
0.26

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

which stocks are currently undervalued?
Intellectia · 20 candidates
Pe Ttm: 0.010 - 15P/B Ratio: <= 1.50Return On Equity: >= 12.0%Target Price Upside Potential: MoreAbovePriceEv Ebitda: <= 10
Ticker
Name
Market Cap$
top bottom
DFDV logo
DFDV
DeFi Development Corp
125.85M
BTCS logo
BTCS
BTCS Inc
83.45M
PSHG logo
PSHG
Performance Shipping Inc
25.73M
QFIN logo
QFIN
Qfin Holdings Inc
1.90B
VIA logo
VIA
Via Renewables Inc
1.43B
SM logo
SM
SM Energy Co
5.25B
price less than $10
Intellectia · 23 candidates
Market Cap: >= 500.00MPrice: <= $10.00Weekly Average Turnover: >= 1,000,000Pe Ttm: 0 - 25Annual Revenue Yoy Growth: >= 10.0%
Ticker
Name
Market Cap$
top bottom
ABEV logo
ABEV
Ambev SA
41.38B
BBD logo
BBD
Banco Bradesco SA
39.45B
SUZ logo
SUZ
Suzano SA
12.05B
YMM logo
YMM
Full Truck Alliance Co Ltd
10.30B
INTR logo
INTR
Inter & Co Inc
3.88B
FUBO logo
FUBO
FuboTV Inc
3.33B
quality stocks below $10
Intellectia · 17 candidates
Market Cap: >= 1000.00MPrice: <= $10.00Weekly Average Turnover: >= 1,000,000Pe Ttm: 5 - 25Return On Equity: >= 10.0%
Ticker
Name
Market Cap$
top bottom
ITUB logo
ITUB
Itau Unibanco Holding SA
86.67B
ABEV logo
ABEV
Ambev SA
41.38B
BBD logo
BBD
Banco Bradesco SA
39.45B
WIT logo
WIT
Wipro Ltd
27.24B
NMR logo
NMR
Nomura Holdings Inc
26.35B
VG logo
VG
Venture Global Inc
22.16B

Whales Holding ARDT

C
Castleknight Management LP
Holding
ARDT
+27.35%
3M Return
G
GoldenTree Asset Management LP
Holding
ARDT
-6.20%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Ardent Health Inc (ARDT) stock price today?

The current price of ARDT is 8.91 USD — it has decreased -1.44

What is Ardent Health Inc (ARDT)'s business?

Ardent Health, Inc., formerly Ardent Health Partners, Inc., is a provider of healthcare in mid-sized urban communities across the United States. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 affiliated providers across six states. It provides both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings. In addition to its 30 acute care hospitals, it operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, ambulatory surgery centers (ASCs), urgent care centers, free-standing emergency departments, and diagnostic imaging centers. It operates a consumer-centric healthcare platform focused on creating relationships with its patients across multiple care settings.

What is the price predicton of ARDT Stock?

Wall Street analysts forecast ARDT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ARDT is13.73 USD with a low forecast of 10.00 USD and a high forecast of 17.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Ardent Health Inc (ARDT)'s revenue for the last quarter?

Ardent Health Inc revenue for the last quarter amounts to 1.60B USD, decreased -0.08

What is Ardent Health Inc (ARDT)'s earnings per share (EPS) for the last quarter?

Ardent Health Inc. EPS for the last quarter amounts to 0.32 USD, decreased -60.49

How many employees does Ardent Health Inc (ARDT). have?

Ardent Health Inc (ARDT) has 19200 emplpoyees as of March 11 2026.

What is Ardent Health Inc (ARDT) market cap?

Today ARDT has the market capitalization of 1.29B USD.